$RXSF MUST READ DD CVS Health $103 NYSE Firm is

New Post Public Reply Private Reply Replies (0) Message Board
MoneyMaker
$RXSF MUST READ DD

CVS Health $103 NYSE Firm is Officially Carrying RX SafeDrug, There’s 7,700 Stores which Generate $140 Billion Annual Sales

PRESCRIPTION DRUG ABUSE - A GLOBAL EPIDEMIC - Rx DrugSAFE - A REAL SOLUTION!

Share Structure as of SEPT. 29,15
A/S 500,000,000 ---- O/S 1.37m
*******Float 250,000*******

INSIDERS BUYING UP EVERY LAST SHARE SINCE THURSDAY ALMOST 100,000,000, ONE FORM 4 WORTH $85,000 >> http://www.otcmarkets.com/stock/RXSF/filings

New Top Rate Website
http://www.rxdrugsafe.com/

DRUG SECURITY AND ADHERENCE Technology and Products that Make a Difference

****There is no other company, nor any other team, that has as much experience and know-how in biometric technology as the Rx Safes****

*****Rx Safes, Inc. holds the exclusive worldwide rights to intellectual property that provides market protection for the fingerprint technology used in the Rx Safes’ products.*****

PATENTED/TRADEMARKS/FDA REGISTERED

Now you thought that was a good reason...Here's where it gets good.

3 NYSE PARTNERS & HUGE Connections >>

McKesson Corp. $179 Billion Annual Sales @ $192.00 PPS on NYSE

Cardinal Health @ $91 Billion Annual Sales @ $79.50 PPS on NYSE

Our current corporate partners include the biggest and most trusted names in the medical device and supply markets such as McKesson and Cardinal Health. We hold several patents and licenses to exclusively develop and offer our products for sale in North America.

Next Huge Distribution PARTNER AMERISOURCE BERGEN $80 Billion Annual Revs & $100 pps on NYSE

We have yet to establish a distribution agreement with Amerisource Bergen and anticipate that this will take approximately 3 months to develop the necessary relationships and establish an agreement.

ALSO HONEYWELL, SENTRY LOCKS, MASTER LOCKS & OVERHEAD COMPANY


https://en.m.wikipedia.org/wiki/AmerisourceBergen

https://en.m.wikipedia.org/wiki/Cardinal_Health ;

https://en.m.wikipedia.org/wiki/McKesson_Corporation

AMAZING CONSUMER & COMMERCIAL PRODUCTS

http://www.rxdrugsafe.com/our-products/consumer-products/
http://www.rxdrugsafe.com/our-products/profes...-products/

Why we are different
Our products and technology are more accurate, secure and convenient than traditional mechanical locks and pin codes.
Our fingerprint technology provides superior controlled access to ONLY authorized persons.
We offer the only biometric interface in portable, battery operated devices to target the healthcare market.
Rx Safes’ technology and products simplify security.
We can work with you to improve your existing products giving them a competitive advantage.
We are pursuing a multi-pronged approached to drug security and safety.

TOP RATE MANAGEMENT & BOARD

http://www.rxdrugsafe.com/our-management-team/
http://www.rxdrugsafe.com/board-of-directors/

CEO Ms. Yarde was personally responsible for over $14 million in sales in the first production year, establishing extensive retail distribution relationships, major OEM partnerships and negotiated deals to acquire two key patents to support the growth of the business. As an entrepreneur, Ms. Yarde founded, owned and operated several private and public companies including a technology consulting organization called TekSource as well as a successful private commercial flooring organization, Gem Flooring, which at its peak employed over 20 installers and generated over $20 million in annual revenues.

Co-Founder Mark Basile led one of those companies to a $460 million dollar public market cap. During his tenure as CEO at bioMETRX, the company pioneered a line of fingerprint home security products, culminating in over $14 million in sales in its first production year. Mr. Basile was also an original founding member of the E-Health Alliance – the worlds largest trade organization located in Washington D.C., focusing on electronic healthcare initiatives with all of the largest healthcare companies and organizations. Mr. Basile was directly instrumental in raising more than $45 million dollars for his prior companies, coordinated corporate takeovers of some of his companies largest competitors.

Mr. Koch , age 49 currently holds the position of Executive Vice President and Chief Sales and Marketing Officer at Tweddle Group, Inc. ANNUAL REVENUES $127,000,000

Here are all the News and Interviews/Videos http://www.rxdrugsafe.com/news/

The most effective solution
See how TV, magazines and industry experts all agree that the protection provided by the Rx DrugSAFE is the most effective way to safeguard your prescription and OTC medications.
FDA Registered
Fingerprint recognition
Quality all steel construction
Simple and easy to use

$RXSF
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 69

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 573

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 343

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 158

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 587

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 116

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 437

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 131

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 265

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 24

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading

Top 5 Most Recently Viewed Articles

WISeKey Enhances Digital ID Solutions Across Africa

Updated Category News Views 199

WISeKey Expands Its Digital Identity Footprint Across Africa WISeKey International Holding Ltd is making significant strides in transforming digital identity solutions not only within Seychelles but also expanding into several other African nations. As a prominent player in cybersecurity, blockchain, and IoT, WISeKey is set to revolutionize how national ID systems...

Continue Reading
How to Send Event Leads Directly into Your CRM

Updated Category Business Views 149

Trade shows and conferences generate some of the highest-intent leads a sales team will ever encounter. Yet many of those conversations never convert—not because the prospect lost interest, but because the follow-up arrived too late or the contact details were lost somewhere between a badge scanner and a spreadsheet. Research from event marketing surveys consistently...

Continue Reading
Dreame Technology's Innovative Smart Home Solutions at CES 2025

Updated Category News Views 474

Dreame Technology Showcases Innovative Solutions at CES 2025 Dreame Technology, a pioneer in smart home solutions, has made waves at CES 2025 with the introduction of its next-generation smart home ecosystem. This new system streamlines home management and enhances everyday living through intelligent appliances that are easy to use and highly efficient. Revolutionizing...

Continue Reading
Astemo Flexes Aftermarket Muscles at 2026 AAPEX & SEMA

Updated Category News Views 374

Ah, nothing gets car enthusiasts more revved up than a good old-fashioned auto show unveiling. Astemo Americas is strutting its stuff at the 2026 AAPEX and SEMA shows, and they're not just shooting the breeze—this company has got some serious aftermarket muscle to flex. Pumping Up the Aftermarket Game Astemo's not sitting on its hands when it comes to expanding its...

Continue Reading
Cocoa Prices Plummet, Boosting Chocolate Makers Before Holidays

Updated Category News Views 253

Cocoa Prices Reach New Lows Recently, cocoa futures dropped to their lowest point in nearly two years, which is quite timely as we approach the season for hot chocolate and festive gifting. This price decline acts as a unique advantage for chocolate manufacturers who are just starting to see some relief after facing escalating ingredient costs over the past year, coupled...

Continue Reading